With the development of the social economy, the quality of people's living standards has improved. The risk of Type 2 diabetes mellitus (T2DM) is greatly increased. CRISPR/Cas9 system can provide more accurate and effective treatment for T2DM. Nowadays, the CRISPR/Cas9 system is still in the scientific research stage in the field of treatment of T2DM, and still has many uncertainties. For example, the off-target problem, the lack of clinical trials and ethical issues. This paper mainly analyzes and summarizes the research of CRISPR/Cas9 system on the treatment of T2DM, so as to provide a more systematic reference for the treatment method for future research. However, this treatment method also has the problem of Off-target. Although CRISPR/Cas9 system has high accuracy, it still has the problem of off-target, which may lead to the accidental injury of normal genes, thus causing unpredictable consequences. Technical problems: Although CRISPR/Cas9 system is relatively simple, it still needs superb technology and complex conditions in actual operation, which increases the treatment cost and time, and the sequelae of later treatment is still unclear. Both need further research by researchers.
Read full abstract